Bridgefront Capital LLC Takes Position in Teladoc Health, Inc. (NYSE:TDOC)

Bridgefront Capital LLC acquired a new position in shares of Teladoc Health, Inc. (NYSE:TDOC) during the 4th quarter, Holdings Channel.com reports. The firm acquired 14,306 shares of the health services provider’s stock, valued at approximately $130,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in TDOC. Smith Anglin Financial LLC acquired a new stake in shares of Teladoc Health during the fourth quarter worth about $108,000. Arkadios Wealth Advisors acquired a new position in shares of Teladoc Health in the fourth quarter valued at approximately $115,000. Nisa Investment Advisors LLC increased its position in shares of Teladoc Health by 20,936.8% during the fourth quarter. Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider’s stock worth $3,874,000 after acquiring an additional 424,180 shares in the last quarter. Westside Investment Management Inc. raised its holdings in shares of Teladoc Health by 43.8% during the fourth quarter. Westside Investment Management Inc. now owns 9,200 shares of the health services provider’s stock worth $84,000 after acquiring an additional 2,800 shares during the period. Finally, KBC Group NV boosted its stake in Teladoc Health by 72.3% in the 4th quarter. KBC Group NV now owns 8,849 shares of the health services provider’s stock worth $80,000 after purchasing an additional 3,714 shares during the period. 76.82% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several analysts have issued reports on TDOC shares. Evercore ISI dropped their price target on Teladoc Health from $8.00 to $7.00 and set an “in-line” rating on the stock in a research note on Thursday, May 1st. Piper Sandler reduced their price target on Teladoc Health from $13.00 to $12.00 and set an “overweight” rating for the company in a research report on Thursday, February 27th. Royal Bank of Canada lifted their price objective on shares of Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Oppenheimer reduced their target price on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a report on Friday, January 24th. Finally, Wells Fargo & Company lowered their price target on shares of Teladoc Health from $10.00 to $8.00 and set an “equal weight” rating on the stock in a research note on Thursday. Twelve analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat, Teladoc Health presently has a consensus rating of “Hold” and an average target price of $9.71.

Insider Activity

In related news, insider Adam C. Vandervoort sold 11,011 shares of the business’s stock in a transaction on Thursday, March 20th. The stock was sold at an average price of $8.42, for a total value of $92,712.62. Following the completion of the sale, the insider now directly owns 64,308 shares in the company, valued at $541,473.36. The trade was a 14.62 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 0.58% of the stock is owned by company insiders.

Teladoc Health Trading Up 0.6 %

Shares of Teladoc Health stock opened at $7.12 on Friday. Teladoc Health, Inc. has a 1 year low of $6.35 and a 1 year high of $15.21. The company has a market capitalization of $1.25 billion, a price-to-earnings ratio of -1.23 and a beta of 1.82. The business has a fifty day simple moving average of $7.75 and a two-hundred day simple moving average of $9.41. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69.

Teladoc Health (NYSE:TDOC) last announced its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The company had revenue of $640.49 million for the quarter, compared to the consensus estimate of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. Research analysts forecast that Teladoc Health, Inc. will post -1.16 EPS for the current year.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.